newsfilter
← Latest News
GlobeNewswire·

Royalty Pharma Acquires OXLUMO™ Royalty Interest From Dicerna for up to $240 Million

Dicerna to receive $180 million upfront and up to $60 million in potential additional milestone payments NEW YORK and LEXINGTON, Mass., April 08, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc...